JP2020511457A5 - - Google Patents

Download PDF

Info

Publication number
JP2020511457A5
JP2020511457A5 JP2019549506A JP2019549506A JP2020511457A5 JP 2020511457 A5 JP2020511457 A5 JP 2020511457A5 JP 2019549506 A JP2019549506 A JP 2019549506A JP 2019549506 A JP2019549506 A JP 2019549506A JP 2020511457 A5 JP2020511457 A5 JP 2020511457A5
Authority
JP
Japan
Prior art keywords
compound
ethyl
chloro
methoxypiperidin
imidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019549506A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020511457A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2018/010670 external-priority patent/WO2018169092A1/en
Publication of JP2020511457A publication Critical patent/JP2020511457A/ja
Publication of JP2020511457A5 publication Critical patent/JP2020511457A5/ja
Pending legal-status Critical Current

Links

JP2019549506A 2017-03-14 2018-03-13 ヒドロキシアルキルチアジアゾール誘導体のn−ホスホノキシメチルプロドラッグ Pending JP2020511457A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201711008754 2017-03-14
IN201711008754 2017-03-14
PCT/JP2018/010670 WO2018169092A1 (en) 2017-03-14 2018-03-13 N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives

Publications (2)

Publication Number Publication Date
JP2020511457A JP2020511457A (ja) 2020-04-16
JP2020511457A5 true JP2020511457A5 (cg-RX-API-DMAC7.html) 2020-07-27

Family

ID=62002340

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019549506A Pending JP2020511457A (ja) 2017-03-14 2018-03-13 ヒドロキシアルキルチアジアゾール誘導体のn−ホスホノキシメチルプロドラッグ

Country Status (6)

Country Link
US (1) US10752647B2 (cg-RX-API-DMAC7.html)
EP (1) EP3596071A1 (cg-RX-API-DMAC7.html)
JP (1) JP2020511457A (cg-RX-API-DMAC7.html)
CA (1) CA3056571C (cg-RX-API-DMAC7.html)
TW (1) TW201840322A (cg-RX-API-DMAC7.html)
WO (1) WO2018169092A1 (cg-RX-API-DMAC7.html)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200526626A (en) 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
ES2430569T3 (es) 2005-02-18 2013-11-21 Astrazeneca Ab Compuestos antibacterianos derivados de piperidina
EP1856103A2 (en) 2005-02-18 2007-11-21 AstraZeneca AB Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
WO2006087548A2 (en) 2005-02-18 2006-08-24 Astrazeneca Ab Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
US20080269214A1 (en) 2005-03-04 2008-10-30 Astrazeneca Ab Pyrrole Derivatives as Dna Gyrase and Topoisomerase Inhibitors
JP2008531673A (ja) 2005-03-04 2008-08-14 アストラゼネカ アクチボラグ 抗菌活性をもつアゼチジン及びピロールの三環式誘導体
BRPI0620196A2 (pt) 2005-12-23 2013-01-15 Astrazeneca Ab composto, processo para a preparaÇço do mesmo, composiÇço farmacÊutica, uso de um composto, e, mÉtodos para a produÇço de um efeito antibacteriano em um animal de sangue quente, para a inibiÇço de dna girase e/ou topoisomerase iv bacteriana em um animal de sangue quente e para o tratamento de uma infecÇço bacteriana em um animal de sangue quente
TW200819437A (en) 2006-08-17 2008-05-01 Astrazeneca Ab Chemical compounds
WO2008020229A2 (en) 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
WO2008020227A2 (en) 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
TW200906412A (en) 2007-06-12 2009-02-16 Astrazeneca Ab Piperidine compounds and uses thereof
TWI498115B (zh) 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
EP2326640A1 (en) 2008-07-30 2011-06-01 Ranbaxy Laboratories Limited Pyrrole carboxylic acid derivatives as antibacterial agents
US8071605B2 (en) 2008-12-12 2011-12-06 Astrazeneca Ab Piperidine compounds for use in the treatment of bacterial infections
TW201026694A (en) 2008-12-12 2010-07-16 Astrazeneca Ab Compound 468
JP2011026305A (ja) * 2009-06-24 2011-02-10 Daiichi Sankyo Co Ltd イミダゾールカルボニル化合物を含有する医薬組成物
EP2616470B1 (en) * 2010-09-13 2016-10-12 Advinus Therapeutics Limited Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications
CA2887375C (en) 2012-10-10 2022-07-05 Vitas Pharma Research Pvt Ltd Inhibitors of dna gyrase for the treatment of bacterial infections
ES2817749T3 (es) 2015-09-30 2021-04-08 Daiichi Sankyo Co Ltd Derivados de hidroxialquil tiadiazol

Similar Documents

Publication Publication Date Title
ES2244666T3 (es) Derivados de acidos 3-(heteroaril-acetamido)-2-oxoazetidina-1-sulfonicos utilizados como agentes antibacterianos.
JP6130600B2 (ja) トリサイクリックベンズオキサボロール化合物、その製造方法および用途
CN101232884B (zh) 作为抗菌剂的喹啉衍生物
EP0603887B1 (en) Bicyclic amine derivatives
AU2016330271B2 (en) Hydroxyalkyl thiadiazole derivatives
US7759482B2 (en) Aminoglycosides as antibiotics
JPH10287669A (ja) 置換アミノメチルピロリジン誘導体
EP3717490B1 (en) Anti-bacterial heterocyclic compounds and their synthesis
KR101413094B1 (ko) 항박테리아제로서의 퀴놀린 유도체
JP2020511457A (ja) ヒドロキシアルキルチアジアゾール誘導体のn−ホスホノキシメチルプロドラッグ
KR20070116958A (ko) 항-감염성 약물과의 배합을 위한 방향족 치환된 펜타디엔산아미드
US20170355671A1 (en) Peripherally substituted monocyclic beta-lactams
KR20000048687A (ko) 피리도벤족사진 유도체
HK1252275B (en) Hydroxyalkyl thiadiazole derivatives
WO2005073238A1 (ja) ピリドベンズオキサジン誘導体
WO2025049804A2 (en) Agents for the treatment of non-replicating bacteria
CN105492422A (zh) 新型吡咯衍生物
WO1996024593A1 (en) Heterocyclic spiro derivatives
CN105452219A (zh) 新型吡咯衍生物
HK1122210B (en) Quinoline derivatives as antibacterial agents